Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Reticulum Cell-Like Sarcoma, Yoshida

triethylenemelamine has been researched along with Reticulum Cell-Like Sarcoma, Yoshida in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MAKINO, S1
SASAKI, M1
KANO, K1
TANAKA, T1
Fox, BW1

Other Studies

2 other studies available for triethylenemelamine and Reticulum Cell-Like Sarcoma, Yoshida

ArticleYear
The cytological effect of chemicals on tumors. XV. Inhibitory effects of podophyllin (or podophyllotoxin) and triethylene melamine, alone and in combination, on ascites tumors of rats.
    Zeitschrift fur Krebsforschung, 1963, Volume: 65

    Topics: Animals; Ascites; Carcinoma; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Liver Neoplasms; P

1963
The sensitivity of a Yoshida sarcoma to methylene dimethane sulphonate.
    International journal of cancer, 1969, Jan-15, Volume: 4, Issue:1

    Topics: Alkylating Agents; Animals; Busulfan; Female; Injections, Intraperitoneal; Neoplasm Recurrence, Loca

1969